Switzerland / The Quest for Alternatives to Animal Testing
Animal testing for medicinal purposes is back under the spotlight in Switzerland after a petition against the…
Louis Haynes |
Editor
Louis was the Senior Analyst and Editor-in-Chief from 2013 to 2019. He currently collaborates with PharmaBoardroom as external editor. Having directed pharmaceuticals & life science projects across 4 continents, he has published over 30 country reports as well as produced analytical studies on trends in blockchain, Pharma M&A and biotechnology. He has a professional background in consultan more...
Articles: Louis Haynes
The Long Read / Switzerland: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…
Cell & Gene Therapy / Collaborative Spirit
One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they…
Cell & Gene Therapy / Reconsidering Manufacturing
Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating…
Cell & Gene Therapy / Funding the Boom
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the…
RWE / Unlocking the Full Potential of Cell & Gene
Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems:…
The Long Read / Belgium: The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
The Long Read / Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be considered only a middling-size…
MEA / The Moroccan Firms Bringing MNCs to Africa
Some of the more entrepreneurial Moroccan local laboratories have spotted an opening to leverage their knowledge of…
The Long Read / The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat…
The Long Read / Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the…
Medtech / The UAE: Early Adopters of Cutting-Edge Solutions
In some respects, is it perhaps the medtech sector that has most to be excited about in the UAE’s domestic…